SCHEMBL1990322

SCHEMBL1990322

Fc1ccc(-c2ccc(-c3ccc(Br)s3)cc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SNCA P37840 1/20 0.50
HSD17B1 P14061 2/20 0.47
HSD17B2 P37059 2/20 0.47
MAPK13 O15264 1/20 0.47
GCGR P47871 1/20 0.47
MAPK12 P53778 1/20 0.47
MAPK11 Q15759 1/20 0.47
MAPK14 Q16539 1/20 0.47
RAB9A P51151 3/20 0.43
KDM4E B2RXH2 2/20 0.43
NPC1 O15118 2/20 0.43
ALDH1A1 P00352 1/20 0.43
HPGD P15428 1/20 0.43
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
MAPT P10636 2/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
PTPN2 P17706 1/20 0.38
PTPN11 Q06124 1/20 0.38
ESRRG P62508 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1995968 0.98 SNCA (0.52) SNCAHSD17B1HSD17B2MAPK13GCGR
SCHEMBL2778388 0.86 SNCA (0.61) SNCARAB9AKDM4ENPC1ALDH1A1
SCHEMBL12562796 0.84 HSD17B1 (0.61) HSD17B1HSD17B2RAB9AKDM4ENPC1
SCHEMBL9933404 0.81 HSD17B1 (0.59) HSD17B1HSD17B2RAB9AKDM4ENPC1
SCHEMBL12562792 0.81 HSD17B1 (0.59) HSD17B1HSD17B2RAB9AKDM4ENPC1
SCHEMBL12562798 0.81 HSD17B1 (0.59) HSD17B1HSD17B2RAB9AKDM4ENPC1
SCHEMBL12562788 0.81 HSD17B1 (0.59) HSD17B1HSD17B2RAB9AKDM4ENPC1
SCHEMBL12581415 0.81 HSD17B1 (0.63) SNCAHSD17B1HSD17B2RAB9AKDM4E
SCHEMBL3329598 0.80 RAB9A (0.52) SNCAHSD17B1HSD17B2RAB9AKDM4E
SCHEMBL12562851 0.79 HSD17B1 (0.61) HSD17B1HSD17B2RAB9AKDM4ENPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2518075-A1 INDUCED LAYER MATERIAL FOR PREPARING NON-PLANAR METAL PHTHALOCYANINE WEAK EPITAXY GROWTH THIN FILM Shanghai Casail Display Technology Ltd. (CN) 2012-10-31 EP disclosed
EP-2518075-A1 INDUCED LAYER MATERIAL FOR PREPARING NON-PLANAR METAL PHTHALOCYANINE WEAK EPITAXY GROWTH THIN FILM Shanghai Casail Display Technology Ltd. (CN) 2012-10-31 EP disclosed
US-20110152541-A1 INDUCING LAYER MATERIALS FOR WEAK EPITAXIAL FILMS OF NON-PLANAR METAL PHTHALOCYANINE SHANGHAI CASAIL DISPLAY TECHNOLOGY LTD. (CN) 2011-06-23 US disclosed
US-20110152541-A1 INDUCING LAYER MATERIALS FOR WEAK EPITAXIAL FILMS OF NON-PLANAR METAL PHTHALOCYANINE SHANGHAI CASAIL DISPLAY TECHNOLOGY LTD. (CN) 2011-06-23 US disclosed
US-20110152541-A1 INDUCING LAYER MATERIALS FOR WEAK EPITAXIAL FILMS OF NON-PLANAR METAL PHTHALOCYANINE SHANGHAI CASAIL DISPLAY TECHNOLOGY LTD. (CN) 2011-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110152541-A1 INDUCING LAYER MATERIALS FOR WEAK EPITAXIAL FILMS OF NON-PLANAR METAL PHTHALOCYANINE CDYL, PAX3, PAXBP1 SNCA 3557/4885HSD17B1 2793/4885HSD17B2 2870/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.